Anthropic is drawing criticism across multiple fronts including decisions around paid plans, infrastructure spending, and business diversification into pharmaceutical development. For healthcare AI vendors and implementers, this matters because Anthropic's Claude models are increasingly embedded in clinical workflows and EHR integrations. Reputational friction and questions about the company's core focus could create uncertainty for healthcare organizations evaluating long-term partnerships with the vendor. The broader signal: healthcare buyers should stress-test their AI vendor dependencies, especially around companies managing competing priorities.